Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have accidentally got pregnant on Mounjaro, stop the medication straight away and contact your GP or midwife as soon as possible. Tirzepatide is not recommended during pregnancy — the medicine's licence is clear on this, and current clinical guidance advises stopping it the moment pregnancy is confirmed or suspected. There is limited human safety data on tirzepatide in pregnancy; most of what exists comes from animal studies, which showed developmental harm at doses relevant to human exposure. That does not tell us with certainty what happens in human pregnancies, but it is enough for prescribers to act cautiously. Your immediate priority is to let your obstetric team know, so they can support you and monitor your pregnancy appropriately. If you have questions about your Mounjaro treatment history, a prescriber can help you put together an accurate timeline for your midwife.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A belief that circulates on forums (and comes up repeatedly in threads about accidentally getting pregnant on Mounjaro) is that GLP-1 medicines might somehow protect against pregnancy. They do not. There is no contraceptive mechanism in tirzepatide, and the medicine carries no such licence or property.
What is true is the reverse: Mounjaro may actually reduce the reliability of oral contraceptives for some women. Because tirzepatide slows gastric emptying, it can affect how the gut absorbs other medicines, including the pill. NHS guidance on the interaction between Mounjaro and oral contraceptives advises adding a barrier method during the first four weeks of treatment and for four weeks after every dose increase. Women who were not aware of this advice may have had a period of reduced contraceptive cover without realising it, which partly explains why unplanned pregnancies do occur among people taking tirzepatide.
Letting that misconception go gently: if you assumed the pen was doing more than it is licensed to do, you are far from alone. The advice going forward is simply to act on what is actually known.
Stopping tirzepatide does not require a gradual taper. Unlike some medicines, Mounjaro can be discontinued immediately. The half-life of tirzepatide is around five days, meaning the medicine clears gradually from your system over the weeks following your last dose, but you do not need to take further injections to wind down.
The MHRA's Mounjaro Summary of Product Characteristics on the eMC states that women of childbearing potential should use contraception during treatment and for at least one month after stopping, pointing to the same wash-out concern from the other direction. That one-month guidance exists for planned stops before attempting conception; if pregnancy has already occurred, the instruction is simply: stop now and contact your healthcare team.
You may notice your appetite returning and some weight regain as the medicine clears. This is expected and is not a clinical emergency. Your midwife or GP can help you plan appropriate nutrition for pregnancy without tirzepatide, and the weight-management conversation can resume after the pregnancy, if and when that is right for you. Our page on what happens when you continue Mounjaro into pregnancy covers the evidence in more detail if you want it.
Animal reproduction studies with tirzepatide showed lower foetal body weight, skeletal abnormalities and increased embryo-foetal death at doses comparable to human therapeutic levels. These findings are the primary basis for the not-recommended guidance. Animal studies do not translate directly to humans, and many medicines that cause harm in rodent studies are used safely in pregnancy. But for tirzepatide specifically, the human dataset is too small to draw conclusions either way, it is a newer medicine, and systematic human pregnancy outcome data simply does not yet exist in meaningful volume.
The NHS guidance on tirzepatide reflects this: the advice is precautionary, not based on established human harm. That distinction matters. It means that if you discover you stopped Mounjaro very early in pregnancy, your midwife is unlikely to assume the worst, but they will want to monitor the pregnancy carefully and record the exposure accurately. Be honest about when you took your last dose. The earlier that information is in your notes, the better placed your care team is.
Questions about your individual situation (how many doses you took, at what stage) are best answered in conversation with your GP or obstetrician, not on a forum. If you have read concerns online about whether Mounjaro can cause a heart attack, that question also has its own evidence base and is worth reviewing separately from the pregnancy considerations. If you are looking for guidance on Mounjaro and breastfeeding after the baby arrives, that question has its own evidence base and is worth a separate conversation with your midwife.
Call your GP surgery today. If you cannot get an appointment quickly, midwifery self-referral is available in most areas of England and Wales, you do not need to wait for a GP appointment to book your booking-in appointment. Be clear that you were taking a prescription weight-management medicine and have just stopped.
If you are experiencing any concerning symptoms (significant abdominal pain, persistent vomiting, or anything that feels urgent) contact 111 or go to your nearest emergency department. These symptoms may have nothing to do with tirzepatide, but they should always be assessed promptly in early pregnancy.
For anyone who has got pregnant on Mounjaro and wants a fuller account of what others in that situation have experienced and what clinicians advise, that page brings together the practical and medical detail in one place. And if you have general questions about private weight-loss treatment after your pregnancy is complete, our free consultation is the right starting point, every case is reviewed individually by a GPhC-registered prescriber before anything is prescribed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.